Reply

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Drs Soleimani, Tabatabaei, and Behrbouz for their correspondence and present our response herein. Firstly, the primary outcome in our study included the change in visual acuity from initial…

read more

Pars Plana Vitrectomy Combined With Either Secondary Scleral Fixated or Anterior Chamber Intraocular Lens Implantation

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Pars Plana Vitrectomy Combined With Either Secondary Scleral Fixated or Anterior Chamber Intraocular Lens Implantation

We read the article published by Melamud and associates, entitled “Pars Plana Vitrectomy Combined With Either Secondary Scleral Fixated or Anterior Chamber Intraocular Lens Implantation.” The article addressed an interesting…

read more

Reply

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We would like to thank Drs Uzun and Pehlivan for their interest in our recent study, which demonstrates the different responses to intravitreal 0.5 mg ranibizumab (IVR) therapy in 2…

read more

Distinct Responsiveness to Intravitreal Ranibizumab Therapy in Polypoidal Choroidal Vasculopathy With Single or Multiple Polyps

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Distinct Responsiveness to Intravitreal Ranibizumab Therapy in Polypoidal Choroidal Vasculopathy With Single or Multiple Polyps

We have read the article published in the Journal by Suzuki and associates: “Distinct responsiveness to intravitreal ranibizumab therapy in polypoidal choroidal vasculopathy with single or multiple polyps.” In that…

read more

Reply

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Reply

I appreciate Dr Grzybowski’s letter regarding a recent editorial about postoperative endophthalmitis prophylaxis. I cannot agree more with every comment that is made. Yes, the peer-reviewed publications are conflicting and,…

read more

Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study

Purpose To compare the efficacy and safety of the European labels of ranibizumab 0.5 mg vs dexamethasone 0.7 mg in patients with macular edema secondary to central retinal vein occlusion (CRVO). Design…

read more

Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours

Purpose To compare the diurnal and nocturnal effects of latanoprostene bunod 0.024% solution with timolol maleate 0.5% solution on intraocular pressure (IOP) and ocular perfusion pressure. Design Prospective, open-label randomized…

read more

Penetrating Keratoplasty for Keratoconus With and Without Resolved Corneal Hydrops: Long-term Results

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Penetrating Keratoplasty for Keratoconus With and Without Resolved Corneal Hydrops: Long-term Results

Purpose To evaluate the long-term risk of endothelial rejection, graft survival, and associated factors following penetrating keratoplasty (PK) for keratoconus, with and without prior resolved corneal hydrops. Design Retrospective cohort…

read more

Reply

Jan 5, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We appreciate the interest of Drs Călugăru in our recently published COMRADE-C trial comparing the clinical efficacy and safety of ranibizumab vs dexamethasone in macular edema secondary to central retinal…

read more
Get Clinical Tree app for offline access